COLFAX CORP (CFXA) Stock Overview
USA - NYSE:CFXA -
CFXA Key Statistics, Chart & Performance
The current stock price of CFXA is 177.71 null. In the past month the price decreased by -2.6%. In the past year, price increased by 10.01%.
CFXA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 27.54 | 95.46B | ||
| ITW | ILLINOIS TOOL WORKS | 25.75 | 76.19B | ||
| OTIS | OTIS WORLDWIDE CORP | 23.65 | 35.83B | ||
| XYL | XYLEM INC | 31.43 | 35.04B | ||
| IR | INGERSOLL-RAND INC | 25.8 | 32.81B | ||
| SYM | SYMBOTIC INC | 358.2 | 31.73B | ||
| DOV | DOVER CORP | 18.6 | 22.85B | ||
| PNR | PENTAIR PLC | 23.48 | 17.97B | ||
| SNA | SNAP-ON INC | 18.38 | 17.97B | ||
| FTV | FORTIVE CORP | 13.7 | 16.55B | ||
| GGG | GRACO INC | 30.18 | 14.00B | ||
| ITT | ITT INC | 29.23 | 13.80B |
Related stock screener links
About CFXA
Company Profile
Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 15,400 full-time employees. The company went IPO on 2008-05-08. The firm provides orthopedic care and fabrication technology products and services. The company operates through two segments: Fabrication Technology and Medical Technology. Fabrication Technology segment is a supplier of welding equipment, cutting equipment, automated welding and cutting systems, and consumables. Medical Technology segment is a provider of orthopedic solutions, providing orthopedic devices, software and services. Its fabrication technology products are marketed under the ESAB brand. ESAB's range of cutting and welding consumables includes electrodes, cored and solid wire and fluxes. The Company, through its subsidiary DJO Global, Inc. (DJO), provides medical devices that provide solutions for musculoskeletal health, vascular health and pain management. The company also provides devices for fracture fixation, joint fusion and soft tissue injury repair. Its brands include Aircast, Chattanooga, Regeneration, COMPEX, DJO Surgical and PROCARE.
Company Info
COLFAX CORP
2711 Centerville Road, Suite 400
Wilmington DELAWARE US
Employees: 15400
Phone: 13022529160.0
COLFAX CORP / CFXA FAQ
What is the stock price of COLFAX CORP today?
The current stock price of CFXA is 177.71 null. The price decreased by -1.33% in the last trading session.
What is the ticker symbol for COLFAX CORP stock?
The exchange symbol of COLFAX CORP is CFXA and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is CFXA stock listed?
CFXA stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for COLFAX CORP stock?
20 analysts have analysed CFXA and the average price target is 229.41 null. This implies a price increase of 29.09% is expected in the next year compared to the current price of 177.71. Check the COLFAX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is COLFAX CORP worth?
COLFAX CORP (CFXA) has a market capitalization of 27.51B null. This makes CFXA a Large Cap stock.
How many employees does COLFAX CORP have?
COLFAX CORP (CFXA) currently has 15400 employees.
What are the support and resistance levels for COLFAX CORP (CFXA) stock?
COLFAX CORP (CFXA) has a support level at 177.7 and a resistance level at 181.27. Check the full technical report for a detailed analysis of CFXA support and resistance levels.
Is COLFAX CORP (CFXA) expected to grow?
The Revenue of COLFAX CORP (CFXA) is expected to grow by 25.16% in the next year. Check the estimates tab for more information on the CFXA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy COLFAX CORP (CFXA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CFXA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CFXA, evaluating the profitability, health, valuation and growth aspects
- COLFAX CORP (CFXA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COLFAX CORP (CFXA) Sales and EPS estimates to see what analysts future expectations are.
- COLFAX CORP (CFXA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COLFAX CORP (CFXA) Insider and Institutional Ownership to learn about the owners and their transactions.
- COLFAX CORP (CFXA) Stock Chart to make your own analysis
- COLFAX CORP (CFXA) Latest news and press-releases to stay up to date.
Does COLFAX CORP (CFXA) stock pay dividends?
CFXA does not pay a dividend.
What is the Price/Earnings (PE) ratio of COLFAX CORP (CFXA)?
The PE ratio for COLFAX CORP (CFXA) is 86.69. This is based on the reported non-GAAP earnings per share of 2.05 and the current share price of 177.71 null. Check the full fundamental report for a full analysis of the valuation metrics for CFXA.
CFXA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CFXA. When comparing the yearly performance of all stocks, CFXA turns out to be only a medium performer in the overall market: it outperformed 67.1% of all stocks.
CFXA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CFXA. CFXA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CFXA Financial Highlights
Over the last trailing twelve months CFXA reported a non-GAAP Earnings per Share(EPS) of 2.05. The EPS increased by 37.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.92% | ||
| ROA | 1.34% | ||
| ROE | 2.33% | ||
| Debt/Equity | 0.35 |
CFXA Forecast & Estimates
20 analysts have analysed CFXA and the average price target is 229.41 null. This implies a price increase of 29.09% is expected in the next year compared to the current price of 177.71.
For the next year, analysts expect an EPS growth of 54.37% and a revenue growth 25.16% for CFXA